Home / Intelligence / Webinars / Navigating the Early Asset Evaluation Journey with Confidence
February 25, 2025 | 1:00 - 1:45 PM ET
Two additional sessions will be offered:
February 26 – 16:00 (UTC +8:00) – Asia/Shanghai
February 26 – 15:00 CET – Europe/Berlin
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.
Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common pitfalls they must avoid to navigate the early asset evaluation journey with confidence.
Key Webinar Topics
- What are the critical questions along the asset evaluation journey?
- How do you identify which indication to prioritize to maximize value?
- To what extent do you enable R&D vs. Commercial to drive the decision?
- How can you drive smart, lean insights and analytics for a new asset?
- When and how do you typically consider regionality in the process?
Featuring
Bami Oshinowo
Partner, Value, Access & Pricing
& London Office Lead
Julie Fleming
Partner
Lauren Peters Radeck
Partner
Monique Marsh
Associate Director &
Co-Head of Trinity Marketing Communications Insights
Which session would you like to register for?
Complete the form below to register for the February 25th session at 1:00 PM ET
Complete the form below to register for the February 26th session at 16:00 UTC+8 – Asia/Shanghai
Complete the form below to register for the February 26th session at 15:00 CET – Europe/Berlin
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Briefs
The “Molecular Optimizer” Archetype: A Strategy for First-Launch Companies to Streamline Their Path to Market
The “molecular optimizer” archetype is a strategy utilized by first-launch companies to optimize existing molecules when developing their first product. Companies using this approach tend to be small and emerging biotech firms that are seeking a foothold to enter the market. The primary benefit of this approach is that the method offers a higher probability […]
Read More
Webinars
Behavioral Science & Concept Testing Research: Getting Deeper Responses than “I Hate the Color Blue”
Available On Demand
High-impact, optimized marketing communication materials are vital, no matter where a brand is in the product lifecycle. Taking tactical research in general—and concept or message testing in particular—to the next level becomes a key focus. Join Lisa Bailey, a Managing Director in Trinity Life Sciences’ Insights Practice, as she hosts a wide-ranging discussion on tips […]
Watch Now
Webinars
Picking Winners: Portfolio Management for a New Era
Available On Demand
Did you know 62% of products launched between September 2019 and December 2021 underperformed expectations in the first year of launch? What is going wrong, and how can we get it right? Join Trinity Life Sciences for a thought-provoking webinar to dive into the first white paper in our Industry Impact Series, Picking Winners: Portfolio Management for […]
Watch Now